| CAS ID: | 333963-40-9 |
| Molecular Formula: | C20H32F2O5 |
| Molecular Weight: | 390.5 g/mol |
| Monoisotopic Mass: | 390.2218 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | RU-0211 | LUBIPROSTONE | AMITIZA |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C20H32F2O5/c1-2-3-11-19(21,22)20(26)12-10-15-14(16(23)13-17(15)27-20)8-6-4-5-7-9-18(24)25/h14-15,17,26H,2-13H2,1H3,(H,24,25)/t14-,15-,17-,20-/m1/s1 | See All |
| InChI Key: | WGFOBBZOWHGYQH-MXHNKVEKSA-N | |
| Smiles: | CCCCC(F)(F)[C@@]1(O)CC[C@@H]2[C@@H](CCCCCCC(=O)O)C(=O)C[C@H]2O1 | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00706004 | Disease | Cystic fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | June 27, 2008 | Last Verified | April 18, 2011 |
| Sponsor | University of Arkansas | ||
Trial Record 2
| ClinicalTrial ID | NCT03386994 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Status | Active, not recruiting | |
| First Received | December 29, 2017 | Last Verified | March 20, 2019 |
| Sponsor | Boehringer Ingelheim | ||
| PubChem: | 157920 |
| ChEMBL: | CHEMBL1201134 |